Daunorubicin 90 mg/m 2 in Acute Myeloid Leukemia Induction: Increased Toxicity in Young Patients

Yates, 1982, Cytosine arabinoside with daunorubicin or adriamycin for therapy of acute myelocytic leukemia: a CALGB study, Blood, 60, 454, 10.1182/blood.V60.2.454.454 Burnett, 2012, Treatment of acute myeloid leukemia: are we making progress?, Hematology Am Soc Hematol Educ Program, 2012, 1, 10.1182/asheducation.V2012.1.1.3797038 Teuffel, 2013, Anthracyclines during induction therapy in acute myeloid leukaemia: a systematic review and meta-analysis, Br J Haematol, 161, 192, 10.1111/bjh.12233 Fernandez, 2009, Anthracycline dose intensification in acute myeloid leukemia, N Engl J Med, 361, 1249, 10.1056/NEJMoa0904544 Lee, 2011, A randomized trial comparing standard versus high-dose daunorubicin induction in patients with acute myeloid leukemia, Blood, 118, 3832, 10.1182/blood-2011-06-361410 Döhner, 2010, Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet, Blood, 115, 453, 10.1182/blood-2009-07-235358 Souto Filho, 2015, Evaluation of bone marrow aspirates in patients with acute myeloid leukemia at day 14 of induction therapy, Diagn Pathol, 10, 122, 10.1186/s13000-015-0365-2 De Pauw, 2008, Clin Infect Dis, 46, 1813, 10.1086/588660 Gorschlüter, 2005, Neutropenic enterocolitis in adults: systematic analysis of evidence quality, Eur J Haematol, 75, 1, 10.1111/j.1600-0609.2005.00442.x Gong, 2015, High doses of daunorubicin during induction therapy of newly diagnosed acute myeloid leukemia: a systematic review and meta-analysis of prospective clinical trials, PLoS One, 10, e0125612, 10.1371/journal.pone.0125612 Devillier, 2015, Comparison of 60 or 90 mg/m(2) of daunorubicin in induction therapy for acute myeloid leukemia with intermediate or unfavorable cytogenetics, Am J Hematol, 90, E29, 10.1002/ajh.23884 Burnett, 2015, A randomized comparison of daunorubicin 90 mg/m2 vs 60 mg/m2 in AML induction: results from the UK NCRI AML17 trial in 1206 patients, Blood, 125, 3878, 10.1182/blood-2015-01-623447 Fernandez, 2015, Beyond the first glance: anthracyclines in AML, Blood, 125, 3828, 10.1182/blood-2015-04-639419